OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo
Emma Guttman‐Yassky, Ester Del Duca, Joel Corrêa da Rosa, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 161-172.e8
Open Access | Times Cited: 19
Emma Guttman‐Yassky, Ester Del Duca, Joel Corrêa da Rosa, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 161-172.e8
Open Access | Times Cited: 19
Showing 19 citing articles:
Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
Julien Séneschal, Mathilde Guyon, Ribal Merhi, et al.
JAMA Dermatology (2025)
Closed Access | Times Cited: 1
Julien Séneschal, Mathilde Guyon, Ribal Merhi, et al.
JAMA Dermatology (2025)
Closed Access | Times Cited: 1
Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE
Stephen A. Bustin
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101249-101249
Open Access | Times Cited: 12
Stephen A. Bustin
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101249-101249
Open Access | Times Cited: 12
Vitiligo: From Pathogenesis to Treatment
Reinhart Speeckaert, Elise Van Caelenberg, Arno Belpaire, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5225-5225
Open Access | Times Cited: 4
Reinhart Speeckaert, Elise Van Caelenberg, Arno Belpaire, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5225-5225
Open Access | Times Cited: 4
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
Samah Omar Ali Alfahl, Abdullateef A. Alzolibani
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1817-1817
Open Access
Samah Omar Ali Alfahl, Abdullateef A. Alzolibani
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1817-1817
Open Access
Proteomics data in vitiligo: a scoping review
Danique Berrevoet, Filip Van Nieuwerburgh, Dieter Deforce, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Danique Berrevoet, Filip Van Nieuwerburgh, Dieter Deforce, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Serum proteome analysis identifies a potential biomarker for axial psoriatic arthritis
Chaofan Lu, Fan Yang, Shihao He, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Chaofan Lu, Fan Yang, Shihao He, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Ta4C3 Nanosheets as a Novel Therapeutic Platform for Photothermal‐Driven ROS Scavenging and Immune Activation against Antibiotic‐Resistant Infections in Diabetic Wounds
Yapeng Wang, Jing Yang, Yunhong Ma, et al.
Small (2024)
Closed Access | Times Cited: 1
Yapeng Wang, Jing Yang, Yunhong Ma, et al.
Small (2024)
Closed Access | Times Cited: 1
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Open Access | Times Cited: 1
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Open Access | Times Cited: 1
Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery
Tian‐Hua Wei, Shuangshuang Zhou, Xiaolong Jing, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access | Times Cited: 1
Tian‐Hua Wei, Shuangshuang Zhou, Xiaolong Jing, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access | Times Cited: 1
Phototherapy in vitiligo
Anuradha Bishnoi, Iltefat Hamzavi
Pigment International (2024) Vol. 11, Iss. 3, pp. 151-166
Open Access | Times Cited: 1
Anuradha Bishnoi, Iltefat Hamzavi
Pigment International (2024) Vol. 11, Iss. 3, pp. 151-166
Open Access | Times Cited: 1
Proteomics data in vitiligo: a scoping review
Danique Berrevoet, Filip Van Nieuwerburgh, Dieter Deforce, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Danique Berrevoet, Filip Van Nieuwerburgh, Dieter Deforce, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
From mice to men: An assessment of preclinical model systems for the study of vitiligo
Wei Wu, Xinju Wang, Kaiqiao He, et al.
Clinical Immunology (2024) Vol. 262, pp. 110171-110171
Closed Access
Wei Wu, Xinju Wang, Kaiqiao He, et al.
Clinical Immunology (2024) Vol. 262, pp. 110171-110171
Closed Access
Pathogenic Mechanism of T Cells in Vitiligo and Research Progress of Targeted Therapy
蓉 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 95-101
Closed Access
蓉 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 95-101
Closed Access
A review of TEC family kinases and their inhibitors in the treatment of alopecia areata
Yinglin An, Fan Zhang
Archives of Dermatological Research (2024) Vol. 316, Iss. 8
Closed Access
Yinglin An, Fan Zhang
Archives of Dermatological Research (2024) Vol. 316, Iss. 8
Closed Access
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses
Elena Peeva, Yuji Yamaguchi, Zhan Ye, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access
Elena Peeva, Yuji Yamaguchi, Zhan Ye, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 9
Open Access
JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence
Kabir Sardana, Aishwarya Muddebihal, Ananta Khurana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 12, pp. 1221-1227
Closed Access
Kabir Sardana, Aishwarya Muddebihal, Ananta Khurana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 12, pp. 1221-1227
Closed Access
